• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Four decades of therapy for AML.

作者信息

Freireich E J

机构信息

University of Texas MD Anderson Cancer Center, Houston 77030, USA.

出版信息

Leukemia. 1998 Sep;12 Suppl 1:S54-6.

PMID:9777898
Abstract

A review of the last four decades of leukemia research and treatment provides a view toward the next four decades. What is learned in leukemia research may apply to the treatment of other cancers. The biology of cancer, the importance of chromosomes, and the suppressor genes may hold the answers to future treatments.

摘要

相似文献

1
Four decades of therapy for AML.
Leukemia. 1998 Sep;12 Suppl 1:S54-6.
2
Preface: significant advances in the biology and therapy of AML over the past four decades.
Best Pract Res Clin Haematol. 2006;19(2):259-62. doi: 10.1016/j.beha.2005.11.009.
3
Acute myeloid leukemia; decided victories, disappointments, and detente: an historical perspective.
Hematology Am Soc Hematol Educ Program. 2008:390. doi: 10.1182/asheducation-2008.1.390.
4
As we look back at the history of BMT, we also look forward to the future of ONS Connect.当我们回顾骨髓移植的历史时,我们也展望肿瘤护理学会连接的未来。
ONS Connect. 2012 Nov;27(11):7.
5
Advances in the treatment of acute myeloid leukemia: from chromosomal aberrations to biologically targeted therapy.急性髓系白血病治疗进展:从染色体畸变到生物靶向治疗
J Cell Biochem. 2008 Aug 15;104(6):2059-70. doi: 10.1002/jcb.21770.
6
Evaluating sixty years of UK trials research in acute myeloid leukaemia: lessons for trial design, past, present and future.评估英国急性髓细胞白血病 60 年临床试验研究:对过去、现在和未来试验设计的启示。
Br J Haematol. 2020 Jan;188(1):29-35. doi: 10.1111/bjh.16357. Epub 2019 Dec 12.
7
Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.急性髓系白血病中 WHO 类型 inv(3)(q21q26.2)/t(3;3)(q21;q26.2) 和其他各种 3q 异常的临床、分子和预后意义。
J Clin Oncol. 2010 Aug 20;28(24):3890-8. doi: 10.1200/JCO.2010.29.2771. Epub 2010 Jul 26.
8
Progress in acute leukemia 1975-1978.1975 - 1978年急性白血病的进展
Haematol Blood Transfus. 1979;23:163-8.
9
Cytogenetics of pediatric acute myeloid leukemia.小儿急性髓系白血病的细胞遗传学
Eur J Haematol. 2009 Nov;83(5):391-405. doi: 10.1111/j.1600-0609.2009.01308.x. Epub 2009 Jun 25.
10
Therapy-related acute myeloid leukemia with favorable cytogenetics: still favorable?伴预后良好细胞遗传学异常的治疗相关性急性髓系白血病:仍然预后良好吗?
Leuk Res. 2012 Dec;36(12):1547-51. doi: 10.1016/j.leukres.2012.09.008. Epub 2012 Sep 29.

引用本文的文献

1
HAG (Homoharringtonine, Cytarabine, G-CSF) Regimen for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis with 2,314 Participants.高三尖杉酯碱、阿糖胞苷、粒细胞集落刺激因子(HAG)方案治疗急性髓系白血病和骨髓增生异常综合征:一项纳入2314名参与者的荟萃分析
PLoS One. 2016 Oct 5;11(10):e0164238. doi: 10.1371/journal.pone.0164238. eCollection 2016.
2
Supportive care in patients with acute leukaemia: historical perspectives.急性白血病患者的支持性护理:历史 perspectives。(这里“historical perspectives”直译为“历史视角”,但感觉表述不太完整准确,你可根据实际情况进一步调整完善)
Blood Transfus. 2015 Apr;13(2):205-20. doi: 10.2450/2014.0080-14. Epub 2014 Oct 23.
3
Increasing the dose of aclarubicin in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) can safely and effectively treat relapsed or refractory acute myeloid leukemia.
增加阿克拉霉素在小剂量阿糖胞苷与阿克拉霉素联合粒细胞集落刺激因子(CAG方案)中的剂量,可安全有效地治疗复发或难治性急性髓系白血病。
Int J Hematol. 2014;99(5):603-8. doi: 10.1007/s12185-014-1528-8. Epub 2014 Mar 13.
4
A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome.CAG(阿糖胞苷、阿克拉霉素、G-CSF)方案治疗 1029 例急性髓系白血病和骨髓增生异常综合征患者的荟萃分析。
J Hematol Oncol. 2011 Nov 14;4:46. doi: 10.1186/1756-8722-4-46.
5
Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemia.伊罗氟芬(MGI 114),一种酰基富烯鬼笔环肽类似物,用于急性白血病患者的I期研究。
Invest New Drugs. 2001;19(1):13-20. doi: 10.1023/a:1006432012394.